A PHASE III, RANDOMIZED, OPEN-LABEL ACTIVE COMPARATOR-CONTROLLED MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF OBINUTUZUMAB IN PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY
Details
Age
Adult
Type of Study
Treatment
Locations
Renal Research Center
University of Colorado Hospital
Principal Investigator
Amber Podoll, MD
Study ID
Protocol Number: 21-4960
More information available at ClinicalTrials.gov: NCT04629248
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers